Baxter International (BAX)

Common Stock
Sell: $19.54|Buy: $20.66|Change: 1.08 (5.77%)

Company profile

Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.

Address

One Baxter Parkway
Deerfield
IL
USA
60015


Telephone

+1 224 948-3085


Sector 

Healthcare


Previous key dates

NameKey Date
Baxter International Inc Fourth Quarter Earnings Conference Call for 20252026-02-12T07:30:00
Baxter International Inc Fourth Quarter Earnings Results for 20252026-02-12T00:00:00
Baxter International Inc Annual Report for 20252026-02-12T00:00:00
J.P. Morgan 2026 Healthcare Conference2026-01-12T14:15:00
Baxter International Inc Other Guidance Call for 20252025-12-02T10:50:00
Baxter International Inc Third Quarter Earnings Conference Call for 20252025-10-30T07:30:00
Baxter International Inc Third Quarter Earnings Results for 20252025-10-30T00:00:00
Baxter International Inc Second Quarter Earnings Conference Call for 20252025-07-31T08:30:00
Baxter International Inc Second Quarter Earnings Result for 20252025-07-31T00:00:00
Bank of America Securities 2025 Health Care Conference2025-05-13T08:40:00
Baxter International Inc Annual General Meeting for 20252025-05-06T09:00:00
Baxter International Inc First Quarter Earnings Conference Call for 20252025-05-01T07:30:00
Baxter International Inc First Quarter Earnings Results for 20252025-05-01T00:00:00
Barclays 27th Annual Global Healthcare Conference2025-03-12T13:00:00
TD Cowen 45th Annual Health Care Conference2025-03-05T13:10:00
Raymond James & Associates’ 46th Annual Institutional Investors Conference2025-03-03T13:05:00
2025 Medtech & Life Sciences Access Day2025-02-27T13:00:00
Baxter International Inc Annual Report for 20242025-02-21T00:00:00
Baxter International Inc Fourth Quarter Earnings Conference Call for 20242025-02-20T07:30:00
Baxter International Inc Fourth Quarter Earnings Result for 20242025-02-20T00:00:00

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2026 AJ Bell. All rights reserved.